Supplemental Table 1
Published: 26 August 2026| Version 1 | DOI: 10.17632/3yg9g9kcrx.1
Contributors:
, , Rebecca Quiñonez, Jaina Gaudette, Mohsen Mokhtari, Redina Bardhi, Mavra Masood, Lydiah Mpyisi, Jasira Ziglar, Joseph Fakhoury, Description
Overview of FDA regulatory pathways, device classifications, and practical interpretations of claims for representative red and near-infrared photobiomodulation (PBM) devices.
Files
Institutions
- Henry Ford HospitalMichigan, Detroit
Categories
Photobiology, Photomedicine